These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 853505)

  • 1. Synthesis and anti-herpes simplex activity of analogues of phosphonoacetic acid.
    Herrin TR; Fairgrieve JS; Bower RR; Shipkowitz NL
    J Med Chem; 1977 May; 20(5):660-3. PubMed ID: 853505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.
    Wohlenberg CR; Walz MA; Notkins AL
    Infect Immun; 1976 May; 13(5):1519-21. PubMed ID: 178609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of herpes simplex virus infection by phosphonoacetic acid.
    Shipkowitz NL; Bower RR; Appell RN; Nordeen CW; Overby LR; Roderick WR; Schleicher JB; Von Esch AM
    Appl Microbiol; 1973 Sep; 26(3):264-7. PubMed ID: 4356456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of esters of phosphonoformic acid and their antiherpes activity.
    Norén JO; Helgstrand E; Johansson NG; Misiorny A; Stening G
    J Med Chem; 1983 Feb; 26(2):264-70. PubMed ID: 6298425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
    Fitzwilliam JF; Griffith JF
    J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutants of herpes simplex virus types 1 and 2 that are resistant to phosphonoacetic acid induce altered DNA polymerase activities in infected cells.
    Hay J; Subak-Sharpe JH
    J Gen Virol; 1976 Apr; 31(1):145-8. PubMed ID: 177727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of some phosphonates with antiherpetic activity.
    Diana GD; Zalay ES; Salvador UJ; Pancic F; Steinberg B
    J Med Chem; 1984 May; 27(5):691-4. PubMed ID: 6325695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1.
    Jofre JT; Schaffer PA; Parris DS
    J Virol; 1977 Sep; 23(3):833-6. PubMed ID: 197275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE; Fondak AA; Buimovici-Klein E
    Infect Immun; 1977 Jun; 16(3):842-8. PubMed ID: 197008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):289-93. PubMed ID: 166611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides.
    Lambert RW; Martin JA; Thomas GJ; Duncan IB; Hall MJ; Heimer EP
    J Med Chem; 1989 Feb; 32(2):367-74. PubMed ID: 2521518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphonomethylether compounds as antiviral agents.
    Martin JC; Hitchcock MJ
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):156-8. PubMed ID: 1648822
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,2,4-Triazoloazine derivatives as a new type of herpes simplex virus inhibitors.
    Deev SL; Yasko MV; Karpenko IL; Korovina AN; Khandazhinskaya AL; Andronova VL; Galegov GA; Shestakova TS; Ulomskii EN; Rusinov VL; Chupakhin ON; Kukhanova MK
    Bioorg Chem; 2010 Dec; 38(6):265-70. PubMed ID: 20947122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
    McCarty JR; Jarratt MT
    J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo.
    Kurokawa M; Hozumi T; Tsurita M; Kadota S; Namba T; Shiraki K
    J Pharmacol Exp Ther; 2001 Apr; 297(1):372-9. PubMed ID: 11259565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.
    Gerstein DD; Dawson CR; O JO
    Antimicrob Agents Chemother; 1975 Mar; 7(3):285-8. PubMed ID: 1137379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the effectiveness of acycloguanosine and phosphonoacetic acid in herpetic infection in cell cultures].
    L'vov ND; Samoĭlovich EO; Barinskiĭ IF
    Vopr Virusol; 1986; 31(2):210-6. PubMed ID: 3014751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.